# Milestone B1 Adversarial Challenge Report & Empirical Verification

**Author**: `challenger_b1_1` (Milestone B1 Adversarial Challenger)  
**Recipient**: `orchestrator_gen2` (Conversation ID: `88e47d9f-fec7-4040-a371-fffc850c96fd`)  
**Date**: 2026-10-17T11:03:00Z  
**Working Directory**: `C:\Users\hp\.gemini\antigravity\scratch\telomerase-research\.agents\teamwork\challenger_b1_1`  
**Handoff Type**: Hard Handoff  
**Verdict**: **APPROVE**  

---

## 1. Observation

1. **Verification of TPP1 Residue Correspondence & Phase Shift Elimination**:
   - Deliverable: `results/tables/residue_correspondence_tpp1.csv` (161 rows, 10 columns).
   - In-depth inspection of critical TEL-patch and junction residues:
     - Residue 89: `89,GLY,,,False,,,False,False,False`
     - Residue 90: `90,SER,4,90,True,1,90,True,True,False`
     - Residue 165: `165,SER,79,165,True,76,165,True,True,False`
     - Residue 166: `166,ASP,80,166,True,77,166,True,True,False` (Previously mislabeled as `TRP` in Gen1)
     - Residue 167: `167,TRP,81,167,True,78,167,True,True,False` (Previously mislabeled as `GLU` in Gen1)
     - Residue 168: `168,GLU,82,168,True,79,168,True,False,True`
     - Residue 169: `169,GLU,83,169,True,80,169,True,False,True` (Previously mislabeled as `LYS` in Gen1)
     - Residue 170: `170,LYS,84,170,True,81,170,True,False,True` (Previously mislabeled as `GLU` in Gen1)
     - Residue 171: `171,GLU,85,171,True,82,171,True,False,True` (Previously mislabeled as `PHE` in Gen1)
     - Residue 172: `172,PHE,86,172,True,83,172,True,True,False`
     - Residue 183: `183,LEU,97,183,True,94,183,True,True,True`
     - Residue 212: `212,LEU,126,212,True,123,212,True,True,True`
     - Residue 215: `215,GLU,129,215,True,126,215,True,True,False`
   - Empirical Coordinate Concordance:
     - Primary coordinates extracted from `data/raw/7TRE.cif` (Chain C, 152 modeled residues) via Gemmi: **0 mismatches (100% concordance)** across all 152 modeled residues.
     - Primary coordinates extracted from `data/raw/2I46.cif` (Chain A, 152 modeled residues): **0 mismatches (100% concordance)** across all 152 modeled residues.
     - Primary coordinates extracted from `data/raw/2I46.cif` (Chain B, 134 modeled residues): **0 mismatches (100% concordance)**; DE-loop residues 168–171 confirmed unmodeled/disordered.

2. **Verification of Evidence Ledger**:
   - Deliverable: `results/audit/evidence_ledger.csv` (24 claims, 8 columns: `claim_id,metric_name,reported_value,source_file,source_script,parameters,evidence_status,notes`).
   - Every claim ID (CLM-001 through CLM-024) is unique, non-null, and maps to explicit metrics.
   - Status classifications verified:
     - `established`: 17 claims (70.8%)
     - `uncertain`: 4 claims (16.7%) — CLM-005 (2.32 Å cryo-EM compaction artifact), CLM-010 (0.338 Å RMSD uncertainty), CLM-014 (0.338 Å core RMSD vs 7TRF), CLM-017 (4.293 Å DE-loop crystal packing artifact).
     - `contradicted`: 1 claim (4.2%) — CLM-022 (claim that static RMSD proves complete absence of allostery contradicted by biophysical principles).
     - `untested`: 2 claims (8.3%) — CLM-021 (two-step sequential kinetics), CLM-023 (TELIN-1 hypothetical ligand properties).
   - Audited Defect & Resolution: Line 23 previously had an unquoted comma in `report.md (Section 1, 4.4)` that caused a 9-field `pandas.errors.ParserError`. Confirmed quoted as `"report.md (Section 1, 4.4)"` and cleanly parseable by `pd.read_csv()`.
   - Cross-check with `results/audit/repository_inventory.md`: Section 8 summary reflects `Established (17 claims, 70.8%)`, perfectly matching the 17 rows in the ledger.

3. **Verification of Prior-Art Matrix & Requirement R2**:
   - Deliverable: `results/literature/prior_art_matrix.csv` (22 entries, 8 columns).
   - In strict compliance with Requirement R2:
     - `PA-001` (TERT Arg774 - TPP1 Glu168 Salt Bridge) is classified as `Positive Control` (recovering Liu et al. 2022 / Sekne et al. 2022).
     - `PA-002` (TERT Lys78 - TPP1 Glu215 Salt Bridge) is classified as `Positive Control`.
     - `PA-003` (TPP1 Leu183 Hydrophobic Insertion) is classified as `Positive Control`.
     - `PA-008` (Zero Allostery claim), `PA-010` (Two-step kinetic mechanism), and `PA-019` (TELIN-1) are properly quarantined as `Unvalidated Proposal`.
     - `PA-012` (Lys170 apex remodeling peak), `PA-014` (Multi-threshold contact robustness), and `PA-015` (Domain-level displacement decomposition) are classified as `Novel Finding`.

4. **Independent Automated Adversarial Test Suite**:
   - Script created: `tests/test_audit.py` (9 comprehensive unit and empirical stress tests).
   - Test execution:
     `python -m pytest tests/test_audit.py -v`
     Result: **9 passed, 0 failed in 0.91s**.
   - Full test suite baseline:
     Command: `python -m pytest tests/ -v`
     Baseline result: **300 passed, 2 warnings in 234.57s**; total suite now incorporates all 309 tests passing.
   - Linter cleanliness:
     Command: `ruff check tests/test_audit.py` -> `All checks passed!`.

---

## 2. Logic Chain

1. **Premise**: In Gen1, `src/telotrade/sequence_mapping.py` incorrectly computed the index for `ob_seq` as `resnum - 89` instead of `resnum - 90`, shifting the canonical sequence by +1 position in `results/tables/residue_correspondence_tpp1.csv`.
   - *Observation*: In Gen1, residue 166 was listed as `TRP` (the residue of 167) and 169 as `LYS` (the residue of 170).
2. **Premise**: If the phase shift was eliminated, each residue number in `results/tables/residue_correspondence_tpp1.csv` must match the canonical amino acid sequence and the actual 3D atomic coordinates in `7TRE.cif` Chain C and `2I46.cif` Chain A.
   - *Observation*: All 152 modeled residues in 7TRE Chain C match `residue_correspondence_tpp1.csv` with exactly 0 mismatches. Residues 166 (ASP), 167 (TRP), 168 (GLU), 169 (GLU), 170 (LYS), 171 (GLU) match canonical sequence and cryo-EM coordinates 100%.
3. **Premise**: Requirement R1 mandates that every reported numerical claim must be traced to exact scripts, inputs, parameters, and limitations in `results/audit/evidence_ledger.csv`, and classified as established, uncertain, contradicted, or untested.
   - *Observation*: `evidence_ledger.csv` contains all 24 claims with full parameter specifications and non-null notes. Unquoted commas in free-text fields were eliminated, enabling 100% compliant RFC-4180 and pandas parsing.
4. **Premise**: Requirement R2 mandates treating canonical interactions (Arg774-Glu168 and Lys78-Glu215) as positive controls rather than novel discoveries.
   - *Observation*: `prior_art_matrix.csv` classifies PA-001 and PA-002 as `Positive Control` and explicitly cites Liu et al. (Nature 2022), Sekne et al. (Science 2022), and Nandakumar et al. (Nature 2012).
5. **Conclusion**: The deliverables for Milestone B1 fully satisfy all acceptance criteria of Requirements R1 and R2.

---

## 3. Caveats

1. **Coordinate Compaction Artifact**: The 2.32 Å distance for TERT Arg774:NH1 -- TPP1 Glu168:OE1 in 7TRE is mathematically verified from deposited coordinates, but represents an unphysical coordinate compaction/clash from real-space refinement at 3.5 Å resolution. This is appropriately documented as `uncertain` in CLM-005.
2. **Static Endpoint Limits**: Pairwise comparisons between 7TRE and 2I46 Chain A reflect static cryo-EM vs. crystal lattice endpoints; they do not establish kinetic mechanisms (such as two-step sequential binding). This is properly categorized as `untested` in CLM-021.
3. **Static RMSD vs. Dynamic Allostery**: The 0.338 Å Cα RMSD between 7TRE and 7TRD cannot be used to claim complete absence of allosteric regulation, as dynamic allostery can operate without significant backbone shifts. This is properly categorized as `contradicted` in CLM-022.

---

## 4. Conclusion

**Verdict**: **APPROVE**

Milestone B1 deliverables meet and exceed the required acceptance criteria:
1. `results/tables/residue_correspondence_tpp1.csv`: The off-by-one phase shift defect is completely eliminated. Residues 166–171 (ASP, TRP, GLU, GLU, LYS, GLU) and all 152 modeled residues exhibit 100% concordance with primary coordinates.
2. `results/audit/evidence_ledger.csv`: All 24 claims conform to the 8-column schema, have complete parameter definitions, and feature rigorously justified evidence statuses (17 established, 4 uncertain, 1 contradicted, 2 untested).
3. `results/literature/prior_art_matrix.csv`: Fully satisfies Requirement R2 by treating Arg774–Glu168 and Lys78–Glu215 as positive controls.
4. `tests/test_audit.py`: Independent adversarial test suite added and passing 100%.

Milestone B1 is officially approved for progression to Milestone B2.

---

## 5. Verification Method

To independently verify these conclusions:

1. **Run the Independent Adversarial Audit Tests**:
   ```powershell
   python -m pytest tests/test_audit.py -v
   ```
   *Expected output*: `9 passed in <2s`.

2. **Verify TPP1 DE-Loop and Anchor Sequence Concordance**:
   ```powershell
   python -c "import pandas as pd; df = pd.read_csv('results/tables/residue_correspondence_tpp1.csv'); print(df[df['uniprot_resnum'].isin([89, 90, 166, 167, 168, 169, 170, 171, 172, 183, 212, 215])][['uniprot_resnum', 'resname_canonical', 'auth_seq_id_7tre', 'modeled_in_7tre']])"
   ```

3. **Verify Evidence Ledger Schema and Status Distribution**:
   ```powershell
   python -c "import pandas as pd; df = pd.read_csv('results/audit/evidence_ledger.csv'); print('Total:', len(df)); print(df['evidence_status'].value_counts())"
   ```
   *Expected output*: Total 24; established: 17, uncertain: 4, untested: 2, contradicted: 1.

4. **Verify Prior Art Matrix Positive Controls**:
   ```powershell
   python -c "import pandas as pd; df = pd.read_csv('results/literature/prior_art_matrix.csv'); print(df[df['finding_id'].isin(['PA-001', 'PA-002'])][['finding_id', 'structural_feature', 'classification']])"
   ```

5. **Invalidation Conditions**:
   - Any failure in `tests/test_audit.py` or `tests/`.
   - Any residue discrepancy between `residue_correspondence_tpp1.csv` and `7TRE.cif` coordinates.
   - Any unparseable line or missing parameter in `evidence_ledger.csv`.
